- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-10-0001514

About Texas Pharmaceuticals Private Limited
Data last updated:
Texas Pharmaceuticals Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 July 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232HR2011PTC043450. Its GSTIN is 06AADCT9364J1ZW (Haryana).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹86 Lakh. It was formerly known as Vivimed Pharmaceuticals Private Limited. It is led by directors including Madhu and Ashok Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #87 Basement Dayal Singh Colony Karnal, Haryana, India – 132001.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.03 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹6.29 Lakh (net margin 0.6%) and EBITDA of ₹41.98 Lakh (EBITDA margin 3.8%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹3.56 Cr and satisfied charges of ₹1.98 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 2 cases are pending.
Texas Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0001514). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website texasusa.in.
Recognitions & Rankings of Texas Pharmaceuticals
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address#87 Basement Dayal Singh Colony Karnal, Haryana, India – 132001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Texas Pharmaceuticals Private Limited
The main business activity of Texas Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Texas Pharmaceuticals Private Limited FY 2025 filings available
Texas Pharmaceuticals Private Limited reported revenue of ₹11.03 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Texas Pharmaceuticals Private Limited
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Texas Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹41.98 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.29 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Texas Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Texas Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Texas Pharmaceuticals Private Limited
Texas Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhu | Director | 16 Dec 2011 | 14 Years 10 Months | Current |
| Ashok Kumar | Director | 08 Aug 2014 | 12 Years 2 Months | Current |
| Arvind Mann | Director | 08 Aug 2014 | 12 Years 2 Months | Current |
| Sachin Garg Also directs: Saphnix Life Sciences Private Limited | Director | 19 Jul 2011 | 15 Years 3 Months | Current |
Peer Comparison of Texas Pharmaceuticals Private Limited
Texas Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RN Chemicals & Pharmaceutical Private Limited | ₹11.08 Cr (FY 2025) | •••• | •••• | 970.0% | •••• | Solan, Himachal Pradesh, India |
| Pilco Healthcare Private Limited | ₹11.07 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Kanpur, Uttar Pradesh, India |
| Osper Formulations Private Limited | ₹11.03 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Rohtak, Haryana, India |
| Gryff Pharmaceuticals Private Limited | ₹11.03 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Lucknow, Uttar Pradesh, India |
| Cisen Pharmaceuticals India Private Limited | ₹11.03 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Salcette, Goa, India |
| Texas Pharmaceuticals Private Limited this company | ₹11.03 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Karnal, Haryana, India |
| Vignesh Life Sciences Pvt Ltd | ₹11.02 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Hyderabad, Telangana, India |
| Alenvision Pharma Private Limited | ₹11.01 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Mumbai, Maharashtra, India |
| Eastern Chemical Industrias Pvt Ltd | ₹11 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Cuttack, Odisha, India |
| Nav2dx Medicare Private Limited | ₹11 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | New Delhi, Delhi, India |
| Nivoxaa Biotech India Private Limited | ₹10.97 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Karnal, Haryana, India |
Peers are the five companies nearest above and the five nearest below Texas Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Texas Pharmaceuticals Private Limited
Texas Pharmaceuticals Private Limited is audited by ANIRUDH JINDAL & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANIRUDH JINDAL & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Texas Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Texas Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Aug 2025 | Canara Bank | ₹46 Lakh | Open |
| 11 Feb 2025 | Canara Bank | ₹60 Lakh | Open |
| 08 Mar 2013 | Canara Bank | ₹2.5 Cr | Open |
| 03 Aug 2023 | Canara Bank | ₹13 Lakh | Satisfied |
| 18 Nov 2016 | Canara Bank | ₹20 Lakh | Satisfied |
Total charge records: 6 View all charges
Legal Cases of Texas Pharmaceuticals Private Limited
Texas Pharmaceuticals Private Limited has 3 court cases on record: 2 filed by Texas Pharmaceuticals, 1 filed against it. 2 cases are pending and 1 is disposed. Status as checked between 29 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Solan, Himachal Pradesh | Court case (Suit For Recovery) | Filed against the company by an individual | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Texas Pharmaceuticals Private Limited
Texas Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 6 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Saphnix Lifesciences | •••• | •••• | •••• |
| Sunvet Pharma Private Limited | •••• | •••• | •••• |
| GG Nutritions | •••• | •••• | •••• |
| MMG Healthcare | •••• | •••• | •••• |
| Shervotech Pharmaceuicals | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Texas Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Texas Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Texas Pharmaceuticals Private Limited
Texas Pharmaceuticals Private Limited has 6 board changes on record since 2011: 4 appointments and 2 cessations. The latest: Arvind Mann was appointed as Director on 08 Aug 2014.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Texas Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Texas Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Texas Pharmaceuticals Private Limited
Texas Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AADCT9364J1ZW | Haryana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Texas Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Texas Pharmaceuticals Private Limited
Texas Pharmaceuticals is an active private limited company based in Karnal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 July 2011 (15+ years old) and is registered under CIN U24232HR2011PTC043450.
Texas Pharmaceuticals reported revenue of ₹11.03 Cr for FY 2025 (up 3% YoY).
Texas Pharmaceuticals has 4 current directors:
- Madhu - Director
- Ashok Kumar - Director
- Arvind Mann - Director
- Sachin Garg - Director
Texas Pharmaceuticals reported a net profit of ₹6.29 Lakh (net margin 0.6%) and EBITDA of ₹41.98 Lakh (EBITDA margin 3.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Texas Pharmaceuticals is -3% over three years and -3% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Texas Pharmaceuticals is 06AADCT9364J1ZW, registered in Haryana.
The CIN (Corporate Identification Number) of Texas Pharmaceuticals is U24232HR2011PTC043450. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Texas Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it. 2 are pending.
Texas Pharmaceuticals was incorporated on 19 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Texas Pharmaceuticals by revenue are RN Chemicals & Pharmaceutical Private Limited, Pilco Healthcare Private Limited, Osper Formulations Private Limited, Gryff Pharmaceuticals Private Limited, Cisen Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Arvind Mann was appointed as Director on 08 Aug 2014. Ashok Kumar was appointed as Director on 08 Aug 2014. Madhu ceased to be Additional Director on 29 Sep 2012. Texas Pharmaceuticals has 6 board changes on record in total.
Yes, Texas Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-10-0001514).